Search

Author/Creator Hou, Jin Lin

3. Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China. Issue 6 (25th March 2018)

Authors:
Wei, Lai; Xie, Qing; Hou, Jin Lin; Jia, Jidong; Li, Wu; Xu, Min; Li, Jun; Wu, Shanming; Cheng, Jun; Jiang, Jianning; Wang, Guiqiang; Yang, Yongfeng; Mou, Zhuangbo; Gao, Zhi Liang; Gong, Guozhong; Niu, Jun Qi; Hu, Peng; Tang, Hong; Lin, Feng; Dou, Xiaoguang
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 33:Issue 6(2018)
Page Start:
1168
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. (February 2019)

Authors:
Wei, Lai; Lim, Seng Gee; Xie, Qing; Văn, Kính Nguyen; Piratvisuth, Teerha; Huang, Yan; Wu, Shanming; Xu, Ming; Tang, Hong; Cheng, Jun; Le Manh, Hung; Gao, Yanhang; Mou, Zhuangbo; Sobhonslidsuk, Abhasnee; Dou, Xiaguang; Thongsawat, Satawat; Nan, Yuemin; Tan, Chee Kiat; Ning, Qin; Tee, Hoi Poh
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 4:Number 2(2019)
Page Start:
127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗